2,363
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Acteoside and ursolic acid synergistically protects H2O2-induced neurotrosis by regulation of AKT/mTOR signalling: from network pharmacology to experimental validation

, , , , , , & show all
Pages 1751-1761 | Received 23 Aug 2021, Accepted 30 Jun 2022, Published online: 14 Sep 2022

References

  • Abate G, Frisoni GB, Bourdon JC, Piccirella S, Memo M, Uberti D. 2020. The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease. Alzheimers Res Ther. 12(1):160–170.
  • Amberger JS, Bocchini CA, Scott AF, Hamosh A. 2019. OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res. 47(D1):D1038–D1043.
  • Amir M, Zhao E, Fontana L, Rosenberg H, Tanaka K, Gao G, Czaja MJ. 2013. Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Cell Death Differ. 20(7):878–887.
  • An HM, Lin C, Gu C, Chen JJ, Sun WX, Jin M, Zhang TL, Qiu MF, Hu B. 2017. Di-Huang-Yi-Zhi herbal formula attenuates amyloid-beta-induced neurotoxicity in PC12 cells. Exp Ther Med. 13(6):3003–3008.
  • Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ, Oddo S. 2013. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies. Aging Cell. 12(3):370–380.
  • Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. 2018. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 14:450–464.
  • Chen SY, Chen TF, Lai LC, Chen JH, Sun Y, Wen LL, Yip PK, Chu YM, Chen YC. 2012. Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease. J Neuroinflamm. 9:21–30.
  • Daina A, Michielin O, Zoete V. 2019. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47(W1):W357–W364.
  • DeTure MA, Dickson DW. 2019. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 14(1):32–50.
  • Doytchinova I, Atanasova M, Valkova I, Stavrakov G, Philipova I, Zhivkova Z, Zheleva-Dimitrova D, Konstantinov S, Dimitrov I. 2018. Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database. J Enzyme Inhib Med Chem. 33(1):768–776.
  • Farmer KM, Ghag G, Puangmalai N, Montalbano M, Bhatt N, Kayed R. 2020. P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease. Acta Neuropathol Commun. 8(1):132–153.
  • Foucquier J, Guedj M. 2015. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 3(3):e00149.
  • Gan D, Zhang W, Huang C, Chen J, He W, Wang A, Li B, Zhu X. 2018. Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway. J Cell Physiol. 233(10):6799–6813.
  • Guo H, Xia D, Liao S, Niu B, Tang J, Hu H, Qian H, Cao B. 2019. Vascular endothelial growth factor improves the cognitive decline of Alzheimer's disease via concurrently inducing the expression of ADAM10 and reducing the expression of beta-site APP cleaving enzyme 1 in Tg2576 mice. J Neurosci Res. 142:49–57.
  • Habtemariam S. 2019. Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression. Oxid Med Cell Longev. 2019:8512048.
  • Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4(1):44–57.
  • Hussain H, Green IR, Ali I, Khan IA, Ali Z, Al-Sadi AM, Ahmed I. 2017. Ursolic acid derivatives for pharmaceutical use: a patent review (2012–2016). Expert Opin Ther Pat. 27(9):1061–1072.
  • King KE, Losier TT, Russell RC. 2021. Regulation of autophagy enzymes by nutrient signaling. Trends Biochem Sci. 46(8):687–700.
  • Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 441(7095):880–884.
  • Kshirsagar V, Thingore C, Juvekar A. 2021. Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder. Metab Brain Dis. 36(1):67–83.
  • Lee B, Shim I, Lee H, Hahm DH. 2011. Rehmannia glutinosa ameliorates scopolamine-induced learning and memory impairment in rats. J Microbiol Biotechnol. 21(8):874–883.
  • Li L, Zhang L, Yang CC. 2016. Multi-target strategy and experimental studies of traditional Chinese medicine for Alzheimer's disease therapy. Curr Top Med Chem. 16(5):537–548.
  • Linnemann AK, Blumer J, Marasco MR, Battiola TJ, Umhoefer HM, Han JY, Lamming DW, Davis DB. 2017. Interleukin 6 protects pancreatic beta cells from apoptosis by stimulation of autophagy. Faseb J. 31(9):4140–4152.
  • Liu X, Chu B, Jin S, Li M, Xu Y, Yang H, Feng Z, Bi J, Wang P. 2021. Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer’s disease. Int J Neurosci. 131(2):154–162.
  • Lu J, Zheng YL, Wu DM, Luo L, Sun DX, Shan Q. 2007. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose. Biochem Pharmacol. 74(7):1078–1090.
  • Luo TT, Lu Y, Yan SK, Xiao X, Rong XL, Guo J. 2020. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective. Chin J Integr Med. 26(1):72–80.
  • Ma D, Luo Y, Huang R, Zhao Z, Wang Q, Li L, Zhang L. 2020. Cornel iridoid glycoside suppresses tau hyperphosphorylation and aggregation in a mouse model of tauopathy through increasing activity of PP2A. Curr Alzheimer Res. 16(14):1316–1331.
  • Marino G, Niso-Santano M, Baehrecke EH, Kroemer G. 2014. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 15(2):81–94.
  • Mohamed T, Shakeri A, Rao PP. 2016. Amyloid cascade in Alzheimer’s disease. Eur J Med Chem. 113:258–272.
  • Obulesu M, Lakshmi MJ. 2014. Apoptosis in Alzheimer’s disease: an understanding of the physiology, pathology and therapeutic avenues. Neurochem Res. 39(12):2301–2312.
  • O’Neill C. 2013. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease. Exp Gerontol. 48:647–653.
  • Pinero J, Bravo A, Queralt-Rosinach N, Gutierrez-Sacristan A, Deu-Pons J, Centeno E, Garcia-Garcia J, Sanz F, Furlong LI. 2017. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45(D1):D833–D839.
  • Prerna K, Dubey VK. 2022. Beclin1-mediated interplay between autophagy and apoptosis: new understanding. Int J Biol Macromol. 204:258–273.
  • Qu YJ, Zhen RR, Zhang LM, Gu C, Chen L, Peng X, Hu B, An HM. 2020. Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. et Zucc. for the treatment of Alzheimer’s disease through a network pharmacology approach. BMC Complement Med Ther. 20(1):157–169.
  • Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, et al. 2010. GeneCards Version 3: the human gene integrator. Database. 2010:baq020.
  • Saha P, Guha S, Biswas SC. 2020. P38K and JNK pathways are induced by amyloid-beta in astrocyte: implication of MAPK pathways in astrogliosis in Alzheimer’s disease. Mol Cell Neurosci. 108:103551.
  • Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, Hiltunen M. 2013. Impaired autophagy and APP processing in Alzheimer’s disease: the potential role of Beclin 1 interactome. Prog Neurobiol. 106-107:33–54.
  • Sharma VK, Singh TG. 2020. Insulin resistance and bioenergetic manifestations: targets and approaches in Alzheimer’s disease. Life Sci. 262:118401.
  • Shiao YJ, Su MH, Lin HC, Wu CR. 2017. Acteoside and isoacteoside protect amyloid beta peptide induced cytotoxicity, cognitive deficit and neurochemical disturbances in vitro and in vivo. Int J Mol Sci. 18(4):895–911.
  • Stanciu GD, Rusu RN, Bild V, Filipiuc LE, Tamba BI, Ababei DC. 2021. Systemic actions of SGLT2 inhibition on chronic mTOR activation as a shared pathogenic mechanism between Alzheimer’s disease and diabetes. Biomedicines. 9(5):576–595.
  • Suzuki A, Iwasaki M, Wagai N. 1997. Involvement of cytoplasmic serine proteinase and CPP32 subfamily in the molecular machinery of caspase 3 activation during Fas-mediated apoptosis. Exp Cell Res. 233(1):48–55.
  • Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. 2016. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 44(D1):D380–384.
  • Tu HY, Yuan BS, Hou XO, Zhang XJ, Pei CS, Ma YT, Yang YP, Fan Y, Qin ZH, Liu CF, et al. 2021. alpha-Synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease. Aging Cell. 20(12):e13522.
  • Van Skike CE, Hussong SA, Hernandez SF, Banh AQ, DeRosa N, Galvan V. 2021. mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer’s disease. J Neurosci. 41(19):4305–4320.
  • Wang CF, Song CY, Wang X, Huang LY, Ding M, Yang H, Wang P, Xu LL, Xie ZH, Bi JZ. 2019. Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of Alzheimer’s disease. Eur Rev Med Pharmacol Sci. 23(8):3542–3550.
  • Wang HQ, Xu YX, Zhu CQ. 2012. Upregulation of heme oxygenase-1 by acteoside through ERK and PI3 K/Akt pathway confer neuroprotection against beta-amyloid-induced neurotoxicity. Neurotox Res. 21(4):368–378.
  • Wang J, Zhang X, Cheng X, Cheng J, Liu F, Xu Y, Zeng J, Qiao S, Zhou W, Zhang Y. 2017. LW-AFC, a new formula derived from Liuwei Dihuang Decoction, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in SAMP8 mouse. Curr Alzheimer Res. 14(2):221–238.
  • Wu Z, Li W, Liu G, Tang Y. 2018. Network-based methods for prediction of drug-target interactions. Front Pharmacol. 9:1134–1148.
  • Xie J, Liang R, Wang Y, Huang J, Cao X, Niu B. 2020. Progress in target drug molecules for Alzheimer’s disease. Curr Top Med Chem. 20(1):4–36.
  • Yoon JH, Youn K, Ho CT, Karwe MV, Jeong WS, Jun M. 2014. p-Coumaric acid and ursolic acid from Corni fructus attenuated beta-amyloid(25–35)-induced toxicity through regulation of the NF-kappaB signaling pathway in PC12 cells. J Agric Food Chem. 62(21):4911–4916.
  • Yu H, Oh-Hashi K, Tanaka T, Sai A, Inoue M, Hirata Y, Kiuchi K. 2006. Rehmannia glutinosa induces glial cell line-derived neurotrophic factor gene expression in astroglial cells via cPKC and ERK1/2 pathways independently. Pharmacol Res. 54(1):39–45.
  • Zhao Y, Zhao B. 2013. Oxidative stress and the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev. 2013:316523.
  • Zhou GX, Zhu HL, Shi XT, Nan Y, Liu WB, Dai LM, Xiong YW, Yi SJ, Cao XL, Xu DX, et al. 2021. Autophagy in Sertoli cell protects against environmental cadmium-induced germ cell apoptosis in mouse testes. Environ Pollut. 270:116241.